GFAP and type 2 diabetes mellitus: It is thus tempting to speculate that the increase in GFAP autoantibody levels in T2D patients is caused by elevated levels of brain-derived GFAP, reflecting neuroinflammatory events which may in turn contribute to the cognitive disturbances seen in these patients.